Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Institute For Regenerative Medicine

Clinical trials sponsored by Astellas Institute For Regenerative Medicine, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1

Scientists test stem cell shot to halt blinding eye disease

Disease control Recruiting now

This is an early-stage study to check the safety of a new treatment called ASP7317 for people with advanced dry age-related macular degeneration (AMD), a condition that causes central vision loss. The treatment involves injecting lab-grown retinal cells under the damaged part of …

Phase: PHASE1 • Sponsor: Astellas Institute for Regenerative Medicine • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC